Description
DSIP 5
Delta Sleep-Inducing Peptide (DSIP) is a naturally occurring neuropeptide primarily investigated for its potential to promote deep slow-wave sleep, regulate stress, and modulate pain.
Key Potential Benefits
- Sleep Improvement: Promotes delta-wave (slow-wave) sleep—the deepest and most physically restorative phase of the sleep cycle. It may help reduce nighttime awakenings and shorten sleep latency (the time it takes to fall asleep) without causing heavy chemical sedation.
- Stress and Cortisol Regulation: Interacts with the hypothalamic-pituitary-adrenal (HPA) axis to help normalize stress hormone levels and lower cortisol, assisting the nervous system in transitioning into a restful state.
- Recovery Support: Indirectly aids athletic recovery, tissue healing, and muscle repair by encouraging deeper rest cycles and potentially influencing growth hormone secretion.
- Pain Modulation: Early clinical and laboratory studies suggest DSIP may possess mild analgesic properties, helping reduce pain perception or discomfort linked with chronic conditions.
Important Safety and Regulatory Status
- Not FDA-Approved: DSIP is an investigational compound and is not approved by the FDA or equivalent regulatory bodies as a medication to treat insomnia or any other medical condition.
- Limited Human Data: While early and anecdotal reports describe it as well-tolerated, large-scale, long-term human clinical trials are lacking, meaning its comprehensive safety and side-effect profiles remain unestablished.
- You can read more about current safety evaluations and structural details in this overview of DSIP Peptide Risks and Benefits.
Reviews
There are no reviews yet.